4 hours ago
1
Bet_Noire/iStock via Getty Images
Weight-loss drugmakers Eli Lilly (LLY) and Novo Nordisk (NVO) (OTCPK:NONOF) are planning to announce new drug pricing deals with the White House, including for their blockbuster obesity therapies, Endpoints News reported on Tuesday, citing sources familiar with the matter.
If
© FBT Company 2025. All rights are reserved
English (US) ·